Showing results (131-140 of 421) with videos related to
Sort By:
Pageof 43
Community Mental Health Journal|August 3, 2001
The incarceration of individuals with severe mental disordersM R Munetz, T P Grande, M R ChambersJournal of Embryology and Experimental Morphology|December 1, 1984
Changes in antibody and complement production in Xenopus laevis during postmetamorphic development revealed in a primary in vivo or in vitro antibody responseR L Lallone, M R Chambers, J D HortonNeurology|March 1, 1991
Proximal posterior cerebral artery occlusion simulating middle cerebral artery occlusionB R Chambers, R J Brooder, G A DonnanPoultry Science|March 1, 1997
The influence of complex carbohydrates on Salmonella typhimurium colonization, pH, and density of broiler cecaJ R Chambers, J L Spencer, H W ModlerAustralian and New Zealand Journal of Medicine|February 1, 1983
Patterns of stroke. An analysis of the first 700 consecutive admissions to the Austin Hospital Stroke UnitB R Chambers, G A Donnan, P F BladinJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 5, 2006
Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspectiveHeidi Schulz, Susan Bigelow, Roxanne Dobish, et al.The Cochrane Database of Systematic Reviews|May 5, 2000
Carotid endarterectomy for asymptomatic carotid stenosisB R Chambers, R X You, G A DonnanJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 27, 2008
Oncology medication safety: a 3D status report 2008Philip E Johnson, Carole R Chambers, Allen J VaidaActa Neurochirurgica. Supplement|April 25, 2009
Low frequency pressure waves of possible autonomic origin in severely head-injured childrenR A Minns, P A Jones, I R ChambersJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 28, 2009
Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective Phase IIISusan Bigelow, Heidi Schulz, Roxanne Dobish, et al.Pageof 43